368 related articles for article (PubMed ID: 25175012)
1. TSC1 controls macrophage polarization to prevent inflammatory disease.
Zhu L; Yang T; Li L; Sun L; Hou Y; Hu X; Zhang L; Tian H; Zhao Q; Peng J; Zhang H; Wang R; Yang Z; Zhang L; Zhao Y
Nat Commun; 2014 Sep; 5():4696. PubMed ID: 25175012
[TBL] [Abstract][Full Text] [Related]
2. Tsc1 is a Critical Regulator of Macrophage Survival and Function.
Fang C; Yu J; Luo Y; Chen S; Wang W; Zhao C; Sun Z; Wu W; Guo W; Han Z; Hu X; Liao F; Feng X
Cell Physiol Biochem; 2015; 36(4):1406-18. PubMed ID: 26159807
[TBL] [Abstract][Full Text] [Related]
3. TSC1 controls IL-1β expression in macrophages via mTORC1-dependent C/EBPβ pathway.
Yang T; Zhu L; Zhai Y; Zhao Q; Peng J; Zhang H; Yang Z; Zhang L; Ding W; Zhao Y
Cell Mol Immunol; 2016 Sep; 13(5):640-50. PubMed ID: 27593484
[TBL] [Abstract][Full Text] [Related]
4. Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality.
Ma A; Wang L; Gao Y; Chang Z; Peng H; Zeng N; Gui YS; Tian X; Li X; Cai B; Zhang H; Xu KF
Hum Mol Genet; 2014 Feb; 23(3):693-705. PubMed ID: 24129405
[TBL] [Abstract][Full Text] [Related]
5. Rheb1 deletion in myeloid cells aggravates OVA-induced allergic inflammation in mice.
Li K; Zhang Y; Liang KY; Xu S; Zhou XJ; Tan K; Lin J; Bai XC; Yang CL
Sci Rep; 2017 Feb; 7():42655. PubMed ID: 28225024
[TBL] [Abstract][Full Text] [Related]
6. The Role of TSC1 in the Macrophages Against
Huang XH; Ma Y; Lou H; Chen N; Zhang T; Wu LY; Chen YJ; Zheng MM; Lou YL; Xie DL
Front Cell Infect Microbiol; 2020; 10():596609. PubMed ID: 33585271
[No Abstract] [Full Text] [Related]
7. The role of tuberous sclerosis complex 1 in regulating innate immunity.
Pan H; O'Brien TF; Zhang P; Zhong XP
J Immunol; 2012 Apr; 188(8):3658-66. PubMed ID: 22412198
[TBL] [Abstract][Full Text] [Related]
8. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
[TBL] [Abstract][Full Text] [Related]
9. The TSC-mTOR pathway regulates macrophage polarization.
Byles V; Covarrubias AJ; Ben-Sahra I; Lamming DW; Sabatini DM; Manning BD; Horng T
Nat Commun; 2013; 4():2834. PubMed ID: 24280772
[TBL] [Abstract][Full Text] [Related]
10. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
[TBL] [Abstract][Full Text] [Related]
11. Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation.
Uhlmann EJ; Li W; Scheidenhelm DK; Gau CL; Tamanoi F; Gutmann DH
Glia; 2004 Aug; 47(2):180-8. PubMed ID: 15185396
[TBL] [Abstract][Full Text] [Related]
12. Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch.
Xiang X; Lan H; Tang H; Yuan F; Xu Y; Zhao J; Li Y; Zhang W
Diabetes; 2015 Feb; 64(2):519-28. PubMed ID: 25213336
[TBL] [Abstract][Full Text] [Related]
13. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.
Yang H; Wang X; Zhang Y; Liu H; Liao J; Shao K; Chu Y; Liu G
J Cell Physiol; 2014 Jan; 229(1):17-26. PubMed ID: 23804073
[TBL] [Abstract][Full Text] [Related]
14. Tuberous Sclerosis Complex 1 Deficiency in Macrophages Promotes Unclassical Inflammatory Response to Lipopolysaccharide
Xu H; Zhao Y; Zhao Q; Shi M; Zhang Z; Ding W; Zhao Y
Aging Dis; 2022 Dec; 13(6):1875-1890. PubMed ID: 36465179
[TBL] [Abstract][Full Text] [Related]
15. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
[TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
17. Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals.
Kimura T; Nada S; Takegahara N; Okuno T; Nojima S; Kang S; Ito D; Morimoto K; Hosokawa T; Hayama Y; Mitsui Y; Sakurai N; Sarashina-Kida H; Nishide M; Maeda Y; Takamatsu H; Okuzaki D; Yamada M; Okada M; Kumanogoh A
Nat Commun; 2016 Oct; 7():13130. PubMed ID: 27731330
[TBL] [Abstract][Full Text] [Related]
18. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
Nobukini T; Thomas G
Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
[TBL] [Abstract][Full Text] [Related]
19. Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells.
Benhamron S; Tirosh B
Eur J Immunol; 2011 Aug; 41(8):2390-6. PubMed ID: 21674478
[TBL] [Abstract][Full Text] [Related]
20. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.
Yang J; Kalogerou M; Gallacher J; Sampson JR; Shen MH
Eur J Cancer; 2013 Apr; 49(6):1479-90. PubMed ID: 23228442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
